Literature DB >> 22466346

Clinical inertia of discharge planning among patients with poorly controlled diabetes mellitus.

Michelle L Griffith1, Jeffrey B Boord, Svetlana K Eden, Michael E Matheny.   

Abstract

OBJECTIVE: We examined the effect of hospital admissions on the medical treatment of poorly controlled diabetes mellitus among Veterans Affairs (VA) patients. RESEARCH DESIGN AND METHODS: This retrospective cohort study included male patients admitted to one of three VA hospitals from July 1, 2002, to August 31, 2009, who were receiving medication therapy for diabetes with hemoglobin A1c (HgbA1c) greater than 8.0%. The primary outcome was a change in preadmission and outpatient prescriptions for diabetes at hospital discharge. Covariates for multivariable logistic regression analysis of the primary outcome were defined a priori and retrieved from the electronic health record.
RESULTS: Of 2025 admissions for 1359 patients, 454 had some change in diabetes medications at discharge (rate of change 22.4%). In an adjusted analysis, higher preadmission HgbA1c [odds ratio (OR) 1.12 per 1.0 U increase; 95% confidence interval (CI) 1.12-1.05; P < 0.001], higher mean blood glucose during admission (OR 1.07 per 10 mg/dl increase; 95% CI 1.05-1.10; P < 0.0001), occurrence of inpatient hypoglycemia (blood glucose < 50 mg/dl; OR 1.82, 95% CI 1.32-2.51, P < 0.001), and inpatient basal insulin therapy (OR 1.71; 95% CI 1.25-2.35; P < 0.001) were associated with higher odds of change in therapy. A total of 656 admissions (32%) demonstrated aggregate clinical inertia with no change in therapy, no documentation of HgbA1c within 60 d of discharge, and no follow-up appointment within 30 d of discharge.
CONCLUSIONS: In this multicenter, retrospective study of patients with poorly controlled diabetes and at least one hospitalization, less than a quarter received a change in outpatient diabetes therapy upon discharge, suggesting widespread clinical inertia. Nearly one third had no change in therapy or subsequent follow-up scheduled.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22466346     DOI: 10.1210/jc.2011-3216

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  Update on inpatient diabetes management: call for action.

Authors:  Guillermo E Umpierrez; Kathleen Dungan
Journal:  Diabetes Technol Ther       Date:  2015-04       Impact factor: 6.118

Review 2.  Glucometrics and Insulinometrics.

Authors:  Bithika M Thompson; Curtiss B Cook
Journal:  Curr Diab Rep       Date:  2017-10-23       Impact factor: 4.810

3.  Correction to: Hospital Readmission of Patients with Diabetes.

Authors:  Daniel J Rubin
Journal:  Curr Diab Rep       Date:  2018-03-13       Impact factor: 4.810

Review 4.  PERSPECTIVES ON LEARNING AND CLINICAL PRACTICE IMPROVEMENT FOR DIABETES IN THE HOSPITAL: A REVIEW OF EDUCATIONAL INTERVENTIONS FOR PROVIDERS.

Authors:  Ariana Pichardo-Lowden; Paul Haidet; Guillermo E Umpierrez
Journal:  Endocr Pract       Date:  2017-02-22       Impact factor: 3.443

Review 5.  Hospital readmission of patients with diabetes.

Authors:  Daniel J Rubin
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

Review 6.  Practical Recommendations for Transitioning Patients with Type 2 Diabetes from Hospital to Home.

Authors:  Amy C Donihi
Journal:  Curr Diab Rep       Date:  2017-07       Impact factor: 4.810

7.  Impact of inpatient diabetes management, education, and improved discharge transition on glycemic control 12 months after discharge.

Authors:  Deborah J Wexler; Catherine C Beauharnais; Susan Regan; David M Nathan; Enrico Cagliero; Mary E Larkin
Journal:  Diabetes Res Clin Pract       Date:  2012-10-01       Impact factor: 5.602

8.  Predischarge and Postdischarge Risk Factors for Hospital Readmission Among Patients With Diabetes.

Authors:  Abhijana Karunakaran; Huaqing Zhao; Daniel J Rubin
Journal:  Med Care       Date:  2018-07       Impact factor: 2.983

9.  Hospital discharge algorithm based on admission HbA1c for the management of patients with type 2 diabetes.

Authors:  Guillermo E Umpierrez; David Reyes; Dawn Smiley; Kathie Hermayer; Amna Khan; Darin E Olson; Francisco Pasquel; Sol Jacobs; Christopher Newton; Limin Peng; Vivian Fonseca
Journal:  Diabetes Care       Date:  2014-08-28       Impact factor: 19.112

10.  Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action.

Authors:  Boris Draznin; Janice Gilden; Sherita H Golden; Silvio E Inzucchi; David Baldwin; Bruce W Bode; Jeffrey B Boord; Susan S Braithwaite; Enrico Cagliero; Kathleen M Dungan; Mercedes Falciglia; M Kathleen Figaro; Irl B Hirsch; David Klonoff; Mary T Korytkowski; Mikhail Kosiborod; Lillian F Lien; Michelle F Magee; Umesh Masharani; Gregory Maynard; Marie E McDonnell; Eti S Moghissi; Neda Rasouli; Daniel J Rubin; Robert J Rushakoff; Archana R Sadhu; Stanley Schwartz; Jane Jeffrie Seley; Guillermo E Umpierrez; Robert A Vigersky; Cecilia C Low; Deborah J Wexler
Journal:  Diabetes Care       Date:  2013-07       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.